Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Kanghong Pharmaceutical
Kanghong Pharmaceutical
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Kanghong Pharmaceutical
Stock Price
¥19.4
2024-10-29
Market Capitalization
¥17.5 B
2024-10-29
Revenue
¥4.5 B
FY, 2025
Kanghong Pharmaceutical Summary
Company Summary
Overview
Kanghong Pharmaceutical (成都康弘药业集团股份有限公司) is a company that produces and sells biological products. It offers capsules, carbon dioxide laser beam steering systems, orally disintegrating tablets, ophthalmic injection, and other products.
Type
Public
Status
Active
Founded
1996
HQ
Cheng Du Shi, CN
|
view all locations
Website
http://cnkh.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
medical devices
Homepage
Linkedin
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Cheng Du Shi
HQ
China
Shu Xi Lu, Jin Niu Qu
Kanghong Pharmaceutical Financials
Summary Financials
Revenue (Q1, 2026)
¥1.0B
Gross profit (Q1, 2026)
¥909.2M
Net income (Q1, 2026)
¥303.2M
Cash (Q1, 2026)
¥6.3B
EBIT (Q1, 2026)
¥346.4M
Enterprise value
$11.2B
Competitors and Similar Companies
TCM Biotech
Healthcare - Public
Neofluidics
Healthcare - Private
Lutonix
Healthcare - Subsidiary
Intra-Cellular Therapies
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top